Dashboard
1
The company declared positive results in Mar'25 after flat results in Dec'24
- OPERATING CASH FLOW(Y) Highest at CNY 71.52 MM
- PRE-TAX PROFIT(Q) At CNY 9.29 MM has Grown at 1,301%
- NET PROFIT(Q) At CNY 10.2 MM has Grown at 312.6%
2
With ROE of 1.68%, it has a fair valuation with a 2.50 Price to Book Value
3
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.27%
0%
-16.27%
6 Months
-9.35%
0%
-9.35%
1 Year
9.75%
0%
9.75%
2 Years
6.11%
0%
6.11%
3 Years
12.78%
0%
12.78%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
PharmaResources (Shanghai) Co., Ltd for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.76%
EBIT Growth (5y)
-46.61%
EBIT to Interest (avg)
10.31
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.47
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
348.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.27%
ROE (avg)
3.33%
Valuation key factors
Factor
Value
P/E Ratio
149
Industry P/E
Price to Book Value
2.50
EV to EBIT
293.76
EV to EBITDA
24.04
EV to Capital Employed
3.08
EV to Sales
3.75
PEG Ratio
NA
Dividend Yield
0.39%
ROCE (Latest)
1.05%
ROE (Latest)
1.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
182.80
134.80
35.61%
Operating Profit (PBDIT) excl Other Income
33.60
21.20
58.49%
Interest
2.10
2.30
-8.70%
Exceptional Items
1.50
-1.00
250.00%
Consolidate Net Profit
12.80
12.30
4.07%
Operating Profit Margin (Excl OI)
55.70%
29.60%
2.61%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 35.61% vs 16.21% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 4.07% vs -30.11% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
542.70
488.50
11.10%
Operating Profit (PBDIT) excl Other Income
69.20
76.60
-9.66%
Interest
9.50
5.60
69.64%
Exceptional Items
5.10
5.60
-8.93%
Consolidate Net Profit
17.10
37.60
-54.52%
Operating Profit Margin (Excl OI)
-15.50%
57.60%
-7.31%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 11.10% vs 2.37% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -54.52% vs -44.05% in Dec 2023
About PharmaResources (Shanghai) Co., Ltd 
PharmaResources (Shanghai) Co., Ltd
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






